Marksans Pharma Q1, Q2, Q3, Q4, FY 2017-18, FY 2016-17 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Marksans Pharma Company Profile :

Marksans Pharma Limited is an Indian company engaged in the business of research, manufacturing and marketing of generic pharmaceutical formulations.

Company’s product portfolio addresses various therapeutic segments, including Pain management, Cough and cold, Anti-diabetic, Cardiovascular system, Central nervous system, Antibiotic, Gastrointestinal, Anti-allergic and Miscellaneous.

Company undertakes research and development initiatives, and offers customer relationship management (CRM) services to global pharmaceutical companies.

Company has a manufacturing facility for the manufacture of oral solid tablets and soft gelatin capsules in Goa; a liquids/ointments/sachets manufacturing facility in Southport, the United Kingdom, and a solid oral dosages manufacturing facility in New York, the United States.

Company supplies products to approximately 20 countries. Its subsidiaries include Nova Pharmaceuticals Australasia Pty Ltd. and Marksans Pharma (UK) Limited.


Marksans Pharma Ltd ResultsBSE Code : 524404
NSE Symbol :  MARKSANS
ISIN No. : INE750C01026
Industry :  Pharmaceuticals
Face Value : Rs. 1.00


If you are an investor who has shares of Marksans Pharma or you are an stock market analyst then i am sure you might for Quarterly Results of Marksans Pharma.

In this article you will find Q1, Q2, Q3, Q4 and FY 2017-18 Results of Marksans Pharma . That’s not all, you can compare those results with previous year i.e., FY 2016-17 Results of Marksans Pharma .

Marksans Pharma Q1 Results 2017-18 :

Marksans Pharma will announce its Q1 FY 2017-18 Results in August 2017. Will soon update the below mentioned table.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Marksans Pharma will announce its Q2 FY 2017-18 Results in the month of October 2017.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Marksans Pharma will announce its Q3 FY 2017-18 Results in the month of January 2018.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Marksans Pharma will announce its Q4 FY 2017-18 Results in the month of April 2018.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Marksans Pharma will announce its FY 2017-18 Results in the month of April 2018.

(Values in Cr.) FY 2017-18 Standalone FY 2017-18 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : We will update the results table above as and when results are announced. Visit again.

Marksans Pharma Previous Year’s Results (FY 2016-17) :

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : If you like this information about Marksans Pharma Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.